-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, D17hqIrlz1vqdMgx3OMwdsCLPKWPYM/bSmx1sy3ipS7SwtWyn3AG19t1uDmlnCqR tnbGgHO25X3VdTmXx33oaQ== 0000897069-09-000631.txt : 20090302 0000897069-09-000631.hdr.sgml : 20090302 20090302172435 ACCESSION NUMBER: 0000897069-09-000631 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20090227 FILED AS OF DATE: 20090302 DATE AS OF CHANGE: 20090302 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: TAYLOR RICHMOND L CENTRAL INDEX KEY: 0001217565 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-10670 FILM NUMBER: 09648735 BUSINESS ADDRESS: STREET 1: TWO BETHESDA METRO CENTER, SUITE 1200 CITY: BETHESDA STATE: MD ZIP: 20814 MAIL ADDRESS: STREET 1: 4155 E LAPALMA AVE SUITE 400 CITY: ANEHEIM STATE: CA ZIP: 92807 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HANGER ORTHOPEDIC GROUP INC CENTRAL INDEX KEY: 0000722723 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093] IRS NUMBER: 840904275 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: TWO BETHESDA METRO CENTER STREET 2: SUITE 1300 CITY: BETHESDA STATE: MD ZIP: 20814 BUSINESS PHONE: 3019860701 MAIL ADDRESS: STREET 1: TWO BETHESDA METRO CENTER STREET 2: SUITE 1300 CITY: BETHESDA STATE: MD ZIP: 20814 FORMER COMPANY: FORMER CONFORMED NAME: SEQUEL CORP DATE OF NAME CHANGE: 19890814 FORMER COMPANY: FORMER CONFORMED NAME: CELLTECH COMMUNICATIONS INC DATE OF NAME CHANGE: 19860304 4 1 form4_rtaylorex.xml X0303 4 2009-02-27 0 0000722723 HANGER ORTHOPEDIC GROUP INC HGR 0001217565 TAYLOR RICHMOND L TWO BETHESDA METRO CENTER, SUITE 1200 BETHESDA MD 20814 0 1 0 0 Executive Vice President Common Stock 2009-02-27 4 M 0 23333 1.64 A 116810 D Common Stock 2009-02-27 4 S 0 23333 13.2416 D 93477 D Option to Buy 14.23 2003-05-30 2012-05-29 Common Stock 46666 46666 D Option to Buy 1.64 2009-02-27 4 M 0 23333 0 D 2002-05-31 2009-05-30 Common Stock 23333 0 D Option to Buy 13.80 2004-08-01 2013-07-31 Common Stock 25000 25000 D These shares were sold at a range of sale prices from $13.22 to $13.30. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Includes (i) unvested restricted shares which total 7,260 shares of stock from an initial grant of 7,260 shares of restricted stock made on November 13, 2008; (ii) unvested restricted shares and fully vested shares which total 40,885 shares of stock from an initial grant of 45,000 shares of restricted stock and performance shares made on August 9, 2007; (iii) unvested restricted shares and fully vested shares which total 32,802 shares of stock from an initial grant of 40,000 shares of restricted stock made on June 12, 2006; (iv) unvested restricted shares and fully vested shares which total 10,915 shares of stock from an initial grant of 20,000 shares of restricted stock made on March 4, 2005; and (v) 1,615 shares of stock which were derived from a previous grant of restricted shares which are now fully vested. All remaining unvested restricted shares will continue to vest at a rate of 25% per year of the original grant amount on the anniversary date of the grant. This option was fully vested on June 23, 2005. This option vested over a four-year period from the date of grant and is now fully vested. /s/ Teri L. Champ, attorney-in-fact 2009-03-02 -----END PRIVACY-ENHANCED MESSAGE-----